Print
Health Care

Wilmington Health CEO Talks Pharma

By Ken Little, posted May 19, 2017
Pharmaceutical manufacturer Pfizer recently asked Wilmington Health CEO Jeff James to participate with other health care industry representatives in a discussion on driving change to bring new medications to market safely and more efficiently.

The panel discussion, overseen by Pfizer Chief Development Officer Rod MacKenzie, included top leaders from Pfizer and also “key healthcare influencers and thought leaders in research, data analytics, patient advocacy, technology, and healthcare delivery systems, which includes organizations like Wilmington Health,” a news release stated.

“It was an amazing opportunity to collaborate with some of the most influential organizations and people in the healthcare arena,” James said in the release. “Every Wilmington Health team member is driven to adapt to a patient-centered healthcare environment that is effectively lowering the cost of care without reducing the value and quality. To be recognized by a global leader like Pfizer as having made real change happen and then asked to participate in the future of healthcare is a humbling and awesome experience.”

James, along with Pfizer leaders and invited guests, participated in “a full-day ideation session” in New York City to develop and refine actions that can improve the patient experience, streamline data capture of drug trials and further embed research practices within the health care delivery system, officials said.

In early March, James also traveled to Orlando, Florida, where he was included in a panel discussion with the top 200 Pfizer developers from around the globe, to discuss ways to drive change and to better understand how to integrate those ideas into future pharmaceutical development practices.

“A driving force in lowering healthcare costs and improving outcomes is the speed with which new medications can safely and effectively get to the patient population,” James said. “If we can assist in creating processes and mechanisms to implement new therapies more quickly, without negatively impacting patient safety, everybody wins.”

James added that patients would get access to medications and become healthier sooner, “and we will be able to remove some of the extremely costly time spent on new drug development from the healthcare system.”
Ico insights

INSIGHTS

SPONSORS' CONTENT
Img 0621

Beware the New Tax Laws!

Karen Durda - Century Accounting and Tax Services, Inc.
Webilm julieformal kellystarbuckcom mg 5471

Traveling for Business, Leisure or Bleisure?

Julie Wilsey - Wilmington International Airport
Corey61

Employers: Does your Job Description Suck?

Corey Lewis - Cape Fear Jobs

Trending News

Live Oak Bank Names New President

Jenny Callison - Apr 23, 2018

Developer Of The Avenue Won't Seek Development Agreement

Cece Nunn - Apr 23, 2018

Corning Credit Union Plans Headquarters Here

Jenny Callison - Apr 25, 2018

New Anthem To Expand To South Front Development

Jessica Maurer - Apr 25, 2018

South State-Park Sterling Merger Now Complete

Jenny Callison - Apr 23, 2018

In The Current Issue

DACA In Limbo, Dreamers Plan Carefully

Kevin Lara was just 8 years old when he, his mother and sister left their home in Guatemala, journeyed through Mexico and crossed the river...


In Case Of GenX

Michael Kiser is one of four plaintiffs in consolidated toxic tort cases, proposed as a class action, filed in U.S. District Court in the Ea...


When Demolition Is The Answer

While reusing a vacant commercial building is often an option, there can be important reasons, local commercial building and real estate exp...

Book On Business

The 2018 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

WilmingtonBiz Expo - Keynote Lunch with John Gizdic, CEO, New Hanover Regional Medical Center
Wilmington's Most Intriguing People of 2017
2017 Health Care Heroes